ArticleTherapeutics and clinical risk management2022
Erratum: Practical Management for Use of Eculizumab in the Treatment of Severe, Refractory, Non-Thymomatous, AChR + Generalized Myasthenia Gravis: A Systematic Review [Erratum].
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.